4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000500
Options or other derivatives
- COO, GENERAL COUNSEL &CORP SEC acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Belloff Neil S. · COO, GENERAL COUNSEL &CORP SEC
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-25 | Grant or award : show line 1 in the form Stock Options | +200,000 | 200,000 | D |
| 2020-02-25 | Grant or award : show line 2 in the form Restricted Stock Units | +100,000 | 100,000 | D |
Loading xslF345X03/form4-02262020_040210.xml…